Enhertu 100mg Powder For Injection 1s (Vial)

Enhertu 100mg Powder For Injection contains Trastuzumab Deruxtecan as its active ingredient, an antibody-drug conjugate used within specialised oncology treatment plans under close medical supervision, generally for HER2-related cancers. If this has been prescribed for you, it's helpful to know that commonly reported side effects include nausea, fatigue, hair loss, or reduced blood cell counts, along with a rare but serious risk of lung-related effects that your care team will monitor closely. Because this is an infusion-based treatment requiring reconstitution, it is prepared and administered exclusively by trained healthcare professionals in a clinical setting. Your oncology team will typically conduct regular scans, blood tests, and lung function assessments throughout treatment to monitor your safety. Prompt reporting of any new cough or breathing difficulty to your care team is an essential part of your treatment journey.

Dosage is individually calculated by your oncologist based on body weight and specific treatment protocol, generally administered once every three weeks. Your treatment schedule and dose will be determined and adjusted solely by your specialist care team.

• Nausea or vomiting
• Fatigue
• Hair loss alopecia
• Reduced blood cell counts increasing infection or bleeding risk
• Lung-related effects rare, requiring close monitoring
• Diarrhoea
• Constipation
• Decreased appetite
• Elevated liver enzymes
• Infusion-related reactions

This unreconstituted powder requires refrigerated storage between 2°C and 8°C, protected from light, with specific cold-chain handling maintained throughout transport and storage. Storage and handling of this product are managed by licensed pharmacy and healthcare professionals in line with strict clinical protocols.

• Attend all scheduled infusion appointments and follow-up scans
• Report any new cough, shortness of breath, or fever immediately to your care team
• Take any pre-medications exactly as instructed before each infusion
• Maintain open communication about all new or worsening symptoms
• Keep a record of all medications and supplements for your care team
• Follow any dietary or activity guidance provided by your oncologist
• Discuss any planned surgical or dental procedures with your oncology team in advance

Enhertu is reconstituted and administered as an intravenous infusion by a qualified healthcare professional in a hospital or specialised infusion centre, generally given once every three weeks as part of your treatment plan. This medication is not self-administered at home. Always follow the treatment schedule and pre-medication instructions set out by your oncology care team.

Enhertu Powder For Injection vials typically have a shelf life of around 24 to 36 months from the date of manufacture when stored correctly and unopened. This product's expiry is verified by the pharmacy and clinical team prior to reconstitution and administration.

The active ingredient is Trastuzumab Deruxtecan 100mg, an antibody-drug conjugate combining a HER2-targeted antibody with a chemotherapy component.

This medication should not be used by individuals with a known hypersensitivity to trastuzumab deruxtecan. It requires very careful evaluation by an oncologist due to the risk of lung-related effects, and is not intended for use during pregnancy due to known risks, which should be discussed with your oncology team based on your full medical history.

Trastuzumab deruxtecan may interact with medications that strongly affect liver enzyme activity, and your oncology team will carefully review all your current medications before and during treatment. There are no major specific food interactions. Always keep your full medication list updated with your care team throughout treatment.

Can Enhertu Injection be sourced for Singapore-based patients through your Malaysia pharmacy?
This is a specialised oncology infusion medication administered exclusively in a clinical setting. Please contact our team directly to discuss availability and coordination with your treating hospital or clinic.

Is a prescription required to purchase this medication?
Yes, this is a specialist oncology medication requiring a valid prescription and coordination with your treating oncologist and clinical team.

How is authenticity verified for a specialised medication like this?
This product is sourced directly from verified manufacturers and authorised distributors, with full batch traceability and documentation provided to the dispensing clinical facility.

How does delivery work for a cold-chain injectable medication like this?
Given its temperature-sensitive nature, this product requires specialised cold-chain logistics coordinated directly between our pharmacy and the receiving clinical facility.

Is it safe to source specialist oncology medication through a Malaysia-based pharmacy?
Yes, when coordinated properly between licensed pharmacies and your treating medical team, cross-border sourcing of specialist medication follows strict regulatory and clinical safety protocols.

Can this medication be shipped directly to a patient's home in Singapore?
No, this infusion medication must be administered by healthcare professionals in a clinical setting and cannot be self-administered or delivered directly to a residential address.

How can I coordinate an order for this medication with my treating hospital?
Please contact our customer support team directly so we can assist with coordinating your order alongside your treating oncology team's requirements.

What should happen if there are concerns about the product's condition upon receipt by the clinical facility?
Any concerns regarding product condition should be raised immediately between the receiving pharmacy or clinical facility and our supply team for prompt resolution.

Is patient information kept confidential throughout this process?
Yes, we adhere to strict data privacy and confidentiality standards for all patient and prescription information throughout the coordination and supply process.